Skip to content
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
Bridgebio
Bridgebio launches phase 1/2 of ‘4th generation EGFR TKI drug’ for lung cancer
Bridgebio, started administering new lung cancer drug’BBT-176′ to patients